Overview


The interface of Disease Risk is clear and easy. Questionnaires may be completed in minutes, and the site provides both a visual and spoken risk estimate for each condition, as well as individualised prevention suggestions. Users can also see what their risk might be if they adopt certain healthy activities. The site's results also include customised screening instructions and recommendations for implementing community-wide health changes. Epidemiologists, physicians, and other health specialists analyse the latest scientific information for each disease on a regular basis, finding known and likely risk factors. This data is then used to create or amend calculations that compare a user's disease risk to the population's average risk for someone of the same age and sex.

Health tests can be used to detect an illness, determine a diagnosis, plan treatment, monitor the condition over time, or check to see if treatment is effective. These tests may be ordered by your doctor as part of a standard examination, to rule out particular diseases and disorders, or to keep track of your health. A health test is a diagnostic or monitoring procedure used to detect, diagnose, or monitor diseases, disease processes, susceptibility, or to determine a treatment plan. Physical and visual examinations, diagnostic imaging, genetic testing, chemical and cellular analysis, all of which are related to clinical chemistry and molecular diagnostics, are commonly performed in a medical setting.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Disease Risk And Health Test Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Disease Risk And Health Test Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • 23andMe
  • MyHeritage
  • LabCorp
  • Myriad Genetics
  • Ancestry.com
  • Quest Diagnostics
  • Gene By Gene
  • DNA Diagnostics Center
  • Invitae
  • IntelliGenetics
  • Ambry Genetics
  • Living DNA
  • EasyDNA
  • Pathway Genomics
  • Centrillion Technology
  • Xcode
  • Color Genomics
  • Anglia DNA Services
  • African Ancestry
  • Canadian DNA Services
  • DNA Family Check
  • Alpha Biolaboratories
  • Test Me DNA
  • 23 Mofang
  • Genetic Health

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Celiac Disease
  • Parkinson Disease
  • Alzheimer Disease
  • Other

By Application

  • Online
  • Offline

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Disease Risk And Health Test Market By Product, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Disease Risk And Health Test Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Disease Risk And Health Test Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Disease Risk And Health Test Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Disease Risk And Health Test Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Celiac Disease
        2. Parkinson Disease
        3. Alzheimer Disease
        4. Other

  • 8.   Disease Risk And Health Test Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Online
        2. Offline

  • 9.   North America Disease Risk And Health Test Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Disease Risk And Health Test Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Disease Risk And Health Test Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Disease Risk And Health Test Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •       1. 23andMe
             1.1. Company Overview
             1.2. Product Portfolio
             1.3. SWOT Analysis
             1.4. Financial Overview
             1.5. Strategic Overview
            2. MyHeritage
             2.1. Company Overview
             2.2. Product Portfolio
             2.3. SWOT Analysis
             2.4. Financial Overview
             2.5. Strategic Overview
            3. LabCorp
             3.1. Company Overview
             3.2. Product Portfolio
             3.3. SWOT Analysis
             3.4. Financial Overview
             3.5. Strategic Overview
            4. Myriad Genetics
             4.1. Company Overview
             4.2. Product Portfolio
             4.3. SWOT Analysis
             4.4. Financial Overview
             4.5. Strategic Overview
            5. Ancestry.com
             5.1. Company Overview
             5.2. Product Portfolio
             5.3. SWOT Analysis
             5.4. Financial Overview
             5.5. Strategic Overview
            6. Quest Diagnostics
             6.1. Company Overview
             6.2. Product Portfolio
             6.3. SWOT Analysis
             6.4. Financial Overview
             6.5. Strategic Overview
            7. Gene By Gene
             7.1. Company Overview
             7.2. Product Portfolio
             7.3. SWOT Analysis
             7.4. Financial Overview
             7.5. Strategic Overview
            8. DNA Diagnostics Center
             8.1. Company Overview
             8.2. Product Portfolio
             8.3. SWOT Analysis
             8.4. Financial Overview
             8.5. Strategic Overview
            9. Invitae
             9.1. Company Overview
             9.2. Product Portfolio
             9.3. SWOT Analysis
             9.4. Financial Overview
             9.5. Strategic Overview
            10. IntelliGenetics
             10.1. Company Overview
             10.2. Product Portfolio
             10.3. SWOT Analysis
             10.4. Financial Overview
             10.5. Strategic Overview
            11. Ambry Genetics
             11.1. Company Overview
             11.2. Product Portfolio
             11.3. SWOT Analysis
             11.4. Financial Overview
             11.5. Strategic Overview
            12. Living DNA
             12.1. Company Overview
             12.2. Product Portfolio
             12.3. SWOT Analysis
             12.4. Financial Overview
             12.5. Strategic Overview
            13. EasyDNA
             13.1. Company Overview
             13.2. Product Portfolio
             13.3. SWOT Analysis
             13.4. Financial Overview
             13.5. Strategic Overview
            14. Pathway Genomics
             14.1. Company Overview
             14.2. Product Portfolio
             14.3. SWOT Analysis
             14.4. Financial Overview
             14.5. Strategic Overview
            15. Centrillion Technology
             15.1. Company Overview
             15.2. Product Portfolio
             15.3. SWOT Analysis
             15.4. Financial Overview
             15.5. Strategic Overview
            16. Xcode
             16.1. Company Overview
             16.2. Product Portfolio
             16.3. SWOT Analysis
             16.4. Financial Overview
             16.5. Strategic Overview
            17. Color Genomics
             17.1. Company Overview
             17.2. Product Portfolio
             17.3. SWOT Analysis
             17.4. Financial Overview
             17.5. Strategic Overview
            18. Anglia DNA Services
             18.1. Company Overview
             18.2. Product Portfolio
             18.3. SWOT Analysis
             18.4. Financial Overview
             18.5. Strategic Overview
            19. African Ancestry
             19.1. Company Overview
             19.2. Product Portfolio
             19.3. SWOT Analysis
             19.4. Financial Overview
             19.5. Strategic Overview
            20. Canadian DNA Services
             20.1. Company Overview
             20.2. Product Portfolio
             20.3. SWOT Analysis
             20.4. Financial Overview
             20.5. Strategic Overview
            21. DNA Family Check
             21.1. Company Overview
             21.2. Product Portfolio
             21.3. SWOT Analysis
             21.4. Financial Overview
             21.5. Strategic Overview
            22. Alpha Biolaboratories
             22.1. Company Overview
             22.2. Product Portfolio
             22.3. SWOT Analysis
             22.4. Financial Overview
             22.5. Strategic Overview
            23. Test Me DNA
             23.1. Company Overview
             23.2. Product Portfolio
             23.3. SWOT Analysis
             23.4. Financial Overview
             23.5. Strategic Overview
            24. 23 Mofang
             24.1. Company Overview
             24.2. Product Portfolio
             24.3. SWOT Analysis
             24.4. Financial Overview
             24.5. Strategic Overview
            25. Genetic Health
             25.1. Company Overview
             25.2. Product Portfolio
             25.3. SWOT Analysis
             25.4. Financial Overview
             25.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients